Search results
Stock market today: Wall Street coasts to the finish line of another winning week
WIVB Buffalo· 7 days agoNEW YORK (AP) — U.S. stocks coasted to the close of another winning week on Friday. The S&P 500 rose...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 2 days agoCEO David Dodd discussed significant advancements in the company's Phase 2 clinical trials,...
Fed Rate Cuts Remain Elusive. Why Markets Can’t Count on Inflation Data for Insight and 5 Other...
Barrons.com· 4 days agoFed officials are also struggling to get a clear idea of what’s happening. There will be plenty of ...
MPR News Podcasts
MPR News· 7 days agoCheck out MPR News podcasts, the latest from Minnesota Today to in-depth conversations on news and culture with Angela Davis and stories from around Minnesota with Cathy Wurzer.
Earnings call: Radiant Logistics posts loss amid challenging market By Investing.com
Investing.com· 5 days agoRadiant Logistics, Inc. (NYSE:RLGT) reported a net loss of $703,000 for the quarter ended March 31,...
GameStop, DJT, Bitcoin Show What the Meme Rally Is Really About, and 5 Other Things to Know Today
Barrons.com· 2 days agoStocks such as AMC and GameStop are skyrocketing, completely divorced from news about the companies....
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 2 days agoLet's find out. Image source: Getty Images. Novavax falls behind First, a quick summary of Novavax's story so far. The vaccine maker's shares soared...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Take-Two CEO on Intercept, Roll7: 'We Didn't Shutter Those Studios'
IGN Videogames· 19 hours agoEarlier this month, Take-Two announced a cost reduction plan that included project cancellations,...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 5 days agoNovavax retains its pipeline rights and could earn substantial royalties from Sanofi's development...